Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5Pain, Postoperative 4Pituitary Neoplasms 3Neoplasms 2Liver Neoplasms 2Delirium 2Central Nervous System Diseases 2Brain Neoplasms 2Supratentorial Neoplasms 1Sleep Initiation and Maintenance Disorders 1Rectal Neoplasms 1Pituitary Diseases 1Pancreatic Neoplasms 1Pain 1Neuroinflammatory Diseases 1Neurofibromatoses 1Neurocognitive Disorders 1Lung Neoplasms 1Kidney Neoplasms 1Hypoxia 1Hydrocephalus 1Headache 1Epilepsy 1Colonic Neoplasms 1Chronic Pain 1Agnosia 1Abdominal Neoplasms 1Abdominal Cancer Surgery 1Abdominal Cancer Surgeries 1

Interventions

Morphine 2dexketoprofen trometamol 1Saline Solution 1Ropivacaine 1Remifentanil 1Propofol 1Lidocaine 1Epinephrine 1Dexmedetomidine 1Dexamethasone 1Analgesics, Opioid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Supratentorial Neoplasms × Dexmedetomidine × Clear all
NCT04607525 2021-03-01

Dexmedetomidine Infusion Effect on Hemodynamic Variables During Craniotomy

Ain Shams University

Phase 4 Completed
40 enrolled

Supratentorial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡